State-dependent modification of sodium channels by lipid-soluble agonists.
D000157:Aconitine / Q000494:pharmacology; D000818:Animals; D001496:Batrachotoxins / Q000494:pharmacology; D001665:Binding Sites; D003634:DDT / Q000494:pharmacology*; D004347:Drug Interactions; D004553:Electric Conductivity; D007306:Insecticides / Q000494:pharmacology; D007473:Ion Channels / Q000187:drug effects*; D008055:Lipids; D011487:Protein Conformation; D012964:Sodium / Q000502:physiology*; D012995:Solubility; D013329:Structure-Activity Relationship; D014701:Veratridine / Q000031:analogs & derivatives / Q000494:pharmacology*; D014702:Veratrine / Q000031:analogs & derivatives*
D001496:Batrachotoxins; D007306:Insecticides; D007473:Ion Channels; D008055:Lipids; D014701:Veratridine; D012964:Sodium; D003634:DDT; D014702:Veratrine; D000157:Aconitine